Joseph Edelman – CTMX history
- Issuer:
- CYTOMX THERAPEUTICS INC.
- Quarters tracked:
- 26 (Q2 2016 → Q1 2026)
- Current shares:
- 10,098,824
- Current value:
- $47.46M
- Peak shares:
- 10,098,824 (Q1 2026)
- Overall change:
- +1261%
| Quarter | Shares | Value | $/Share | Share Δ | Δ% |
|---|---|---|---|---|---|
| Q1 2026 | 10,098,824 | $47.46M | $4.70 | +418,639 | +4% |
| Q4 2025 | 9,680,185 | $41.24M | $4.26 | 0 | 0% |
| Q3 2025 | 9,680,185 | $30.88M | $3.19 | +2,686,539 | +38% |
| Q2 2025 | 6,993,646 | $15.88M | $2.27 | +6,993,646 | +100% |
| Q3 2021 | SOLD | — | — | -1,640,957 | -100% |
| Q2 2021 | 1,640,957 | $10.39M | $6.33 | -513,017 | -24% |
| Q1 2021 | 2,153,974 | $16.65M | $7.73 | -423,069 | -16% |
| Q4 2020 | 2,577,043 | $16.88M | $6.55 | 0 | 0% |
| Q3 2020 | 2,577,043 | $17.14M | $6.65 | 0 | 0% |
| Q2 2020 | 2,577,043 | $21.47M | $8.33 | -676,880 | -21% |
| Q1 2020 | 3,253,923 | $24.96M | $7.67 | 0 | 0% |
| Q4 2019 | 3,253,923 | $27.04M | $8.31 | 0 | 0% |
| Q3 2019 | 3,253,923 | $24.01M | $7.38 | +100,000 | +3% |
| Q2 2019 | 3,153,923 | $35.39M | $11.22 | -20,000 | -1% |
| Q1 2019 | 3,173,923 | $34.12M | $10.75 | +262,208 | +9% |
| Q4 2018 | 2,911,715 | $43.59M | $14.97 | +250,000 | +9% |
| Q3 2018 | 2,661,715 | $49.24M | $18.50 | +740,000 | +39% |
| Q2 2018 | 1,921,715 | $43.93M | $22.86 | -287,097 | -13% |
| Q1 2018 | 2,208,812 | $62.84M | $28.45 | -281,569 | -11% |
| Q4 2017 | 2,490,381 | $52.57M | $21.11 | +1,100,000 | +79% |
| Q3 2017 | 1,390,381 | $25.26M | $18.17 | 0 | 0% |
| Q2 2017 | 1,390,381 | $21.55M | $15.50 | -140,278 | -9% |
| Q1 2017 | 1,530,659 | $26.43M | $17.27 | +606,896 | +66% |
| Q4 2016 | 923,763 | $10.15M | $10.99 | +923,763 | +100% |
| Q3 2016 | SOLD | — | — | -742,021 | -100% |
| Q2 2016 | 742,021 | $7.58M | $10.21 | — | NEW |